Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07344597
Prospective Comparative Study of Hypofractionated Adjuvant Radiotherapy in 2 Virsus 3 Weeks in Breast Cancer
Sponsor: Salwa Shawky Bakeet Ali
View on ClinicalTrials.gov
Summary
To compare the efficacy and safety of two hypofractionated adjuvant radiotherapy regimens 34 Gy in 10 fractions versus 40.05 Gy in 15 fractions in patients with breast cancer treated at the South Egypt Cancer Institute.
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
OBSERVATIONAL
Enrollment
70
Start Date
2026-01
Completion Date
2027-02
Last Updated
2026-01-15
Healthy Volunteers
No
Conditions
Interventions
DEVICE
radiotherapy
Hypofractionated Adjuvant Radiotherapy in 2 versus 3 Weeks of Breast Cancer and effect skin toxicity and over all survival
Locations (1)
Assuit
Asyut, Egypt